DNAG To Be Acquired By Nanobac Pharmaceuticals Inc


Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) announced today that a signed letter of intent for the acquisition of DNAPrint Genomics, Inc., has been completed,with the acquisition first having to be approved by DNAPrint Genomics shareholders. DNAG has traded 12,585,000 shares as of mid-day and shown a gain off 33.33% in share price increase since this morning's open.
1000 Penny Stocks